TB-500 + BPC-157 Stack

If you've spent any time in the biohacking or performance optimization space, you've likely heard about stacking TB-500 and BPC-157. This combination has become the go-to healing protocol for athletes, biohackers, and forward-thinking practitioners dealing with injuries that won't heal, chronic inflammation, or accelerated recovery goals.

The rationale is mechanistically sound: BPC-157 and TB-500 promote healing through complementary pathways. Where BPC-157 excels at angiogenesis (new blood vessel formation) and nitric oxide modulation, TB-500 promotes cell migration, reduces inflammation through different mechanisms, and supports tissue remodeling. Together, they address multiple stages of the healing cascade simultaneously.

Disclaimer: Both BPC-157 and TB-500 are research peptides, not approved medications. The vast majority of evidence comes from animal studies. Nothing in this guide constitutes medical advice. Use only under the guidance of a qualified healthcare provider.

TB-500: What It Is and How It Works

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid peptide found in virtually all human cells. Thymosin Beta-4 is one of the most abundant intracellular peptides in the body and plays a critical role in tissue repair and regeneration.

TB-500's primary mechanisms of action:

• Cell migration: TB-500 upregulates actin, a cell-building protein essential for cell migration to injury sites. Faster cell migration = faster tissue repair.
• Anti-inflammatory: Reduces inflammatory cytokines through pathways distinct from BPC-157, providing complementary inflammation reduction.
• Tissue remodeling: Promotes the formation of new blood vessels and muscle tissue fibers while reducing scar tissue (fibrosis).
• Systemic distribution: Unlike BPC-157, which works best when injected near the injury site, TB-500 has a long half-life and distributes systemically. This means it can reach injuries throughout the body regardless of injection site.

BPC-157: Quick Overview

For a comprehensive deep dive, see our full BPC-157 Complete Guide. In summary:

• Angiogenesis: Promotes new blood vessel formation at injury sites, delivering nutrients and oxygen critical for healing.
• Nitric oxide modulation: Context-dependent NO regulation that supports healing environments.
• GH receptor upregulation: May make tissues more responsive to circulating growth factors.
• Gut healing: Originally isolated from gastric juice, BPC-157 has extensive gastroprotective research.
• Local action: Most effective when injected subcutaneously near the injury site for musculoskeletal issues.

Why Stack Them? The Synergy

The BPC-157 + TB-500 stack is greater than the sum of its parts because they target different — and complementary — stages of the healing process:

Think of it this way: BPC-157 builds the infrastructure (new blood vessels and growth factor sensitivity), while TB-500 mobilizes the repair crews (cell migration and tissue remodeling). Using both creates a comprehensive healing environment that addresses the injury from multiple angles simultaneously.

The Protocol: Exact Dosing

The following protocol is compiled from published research dosing, clinical practitioner recommendations, and established community protocols. Individual response varies — always start conservative and adjust based on your experience and any guidance from your healthcare provider.

Phase 1: Loading (Weeks 1-4)

The loading phase uses higher TB-500 doses to establish tissue saturation. BPC-157 is dosed consistently throughout.

• BPC-157: 250-500 mcg subcutaneous, 2x daily (morning and evening). Inject as close to the injury site as practical.
• TB-500: 5-10 mg subcutaneous, 2x per week (e.g., Monday and Thursday). Can be injected anywhere — abdomen, love handles, or deltoids.
• Timing: Both on an empty stomach. BPC-157 morning and before bed. TB-500 on training off-days if possible.

Phase 2: Maintenance (Weeks 5-8)

After the loading phase, TB-500 dose is reduced while BPC-157 continues at the same dose.

• BPC-157: 250-500 mcg subcutaneous, 2x daily (same as loading).
• TB-500: 2-5 mg subcutaneous, 1x per week.
• Assessment: By week 6-8, most users report significant improvement. If the issue has resolved, begin tapering off. If not, a second 4-week loading cycle may be appropriate after a 2-week break.

Cycle Duration and Breaks

Standard cycle: 8-12 weeks total, followed by a break of at least 4 weeks. The break allows the body's natural healing processes to consolidate the gains made during the peptide cycle. Some practitioners use ongoing low-dose BPC-157 (250 mcg/day) for gut health maintenance beyond the formal cycle.

Reconstitution Guide

Both peptides typically arrive as lyophilized (freeze-dried) powder in small vials. They must be reconstituted with bacteriostatic water (BAC water) before injection.

What You Need

• Bacteriostatic water (BAC water): Sterile water with 0.9% benzyl alcohol as a preservative. NOT sterile water or saline — those don't have preservative and allow bacterial growth.
• Insulin syringes: 29-31 gauge, 1mL. Used for both reconstitution and injection.
• Alcohol swabs: To sterilize vial tops before drawing.

Reconstitution Steps

1. Wipe the tops of both the peptide vial and BAC water vial with alcohol swabs.
2. Draw the desired amount of BAC water into a syringe. A common ratio: 2mL BAC water per 5mg peptide vial.
3. Critical: Inject the BAC water slowly down the side of the vial — do NOT spray directly onto the powder. This can damage the peptide.
4. Gently swirl (do NOT shake) until fully dissolved. The solution should be clear.
5. Store reconstituted peptide in the refrigerator (36-46°F / 2-8°C). Use within 3-4 weeks of reconstitution.

Calculating Your Dose

If you reconstitute a 5mg BPC-157 vial with 2mL BAC water:

• 5mg / 2mL = 2.5mg per mL = 2,500 mcg per mL
• 250 mcg dose = 0.1 mL (10 units on an insulin syringe)
• 500 mcg dose = 0.2 mL (20 units on an insulin syringe)

For a 10mg TB-500 vial with 2mL BAC water:

• 10mg / 2mL = 5mg per mL
• 5mg dose = 1.0 mL (100 units — full insulin syringe)
• 2.5mg dose = 0.5 mL (50 units)

Sourcing: The Most Critical Factor

The peptide market is unregulated. The difference between a reputable source and a bad one is the difference between injecting a pure, accurately-dosed compound and injecting unknown substances. This is not an area to cut costs.

What to look for in a peptide source:

• Third-party lab testing: Every batch tested by an independent lab. Results publicly available, not just on request.
• Certificates of Analysis (COAs): Should show HPLC purity (>98%), mass spectrometry verification, endotoxin testing, and sterility testing.
• Consistent quality over time: Check community reviews and reports. A source that was good 6 months ago may have changed suppliers.
• Proper packaging: Argon-sealed vials, lyophilized powder (not pre-mixed solutions), appropriate labeling.

Expected Timeline and Results

Individual results vary significantly based on injury severity, type, chronicity, and individual biology. General expectations:

Realistic expectations: BPC-157 and TB-500 accelerate the body's natural healing processes — they are not magic. A severely torn tendon won't heal in 2 weeks regardless of peptide use. But many users report healing timelines 30-50% faster than expected, reduced pain earlier in recovery, and better tissue quality (less scar tissue) at the end.

Frequently Asked Questions

Can I take BPC-157 without TB-500 (or vice versa)?

Yes. Both peptides work independently. If cost is a factor, BPC-157 alone is the better starting point for most musculoskeletal injuries due to stronger published evidence. TB-500 alone is preferred for systemic inflammation, flexibility issues, or when you want the convenience of less frequent injections.

Can I take BPC-157 orally in this stack?

BPC-157 can be taken orally and maintains gastric stability. However, for musculoskeletal injuries, subcutaneous injection near the injury site is generally considered more effective for localized healing. Oral BPC-157 is best suited for gut-specific issues. TB-500 is injectable only — oral administration is not viable.

Are there any negative interactions between BPC-157 and TB-500?

No negative interactions have been reported in the published literature or in clinical practice. The two peptides work through complementary mechanisms and are commonly used together by practitioners specializing in regenerative medicine.

Can I use this stack while training?

Yes — and most users do. The stack is designed to accelerate recovery while maintaining activity. However, if you have an acute injury, training load should be managed appropriately regardless of peptide use. The peptides support healing; they don't make you invulnerable to re-injury.

Should I use insulin syringes or regular syringes?

Insulin syringes (29-31 gauge) are strongly preferred for subcutaneous peptide injection. They are minimally painful, deliver accurate small volumes, and are widely available. There is no need for larger gauge needles or intramuscular injection for either peptide.